$81.28
-0.07-0.09%
Last update: Dec 15, 12:19 PM
Comments
Loading...
Tarsus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:TARS | Benzinga
Tarsus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 24
EPS Estimate
$-0.070
Quarterly Revenue Estimate
$143.46M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$366.10M
Analyze the earnings history of Tarsus Pharmaceuticals using advanced sorting and filters.
Tarsus Pharmaceuticals (TARS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $-0.30 | $-0.34 | 11.8 % |
| Q2 | 2025-08-06 | $-0.48 | $-0.35 | -37.1 % |
| Q1 | 2025-05-01 | $-0.64 | $-0.63 | -1.59 % |
| Q4 | 2025-02-25 | $-0.60 | $-0.82 | 26.8 % |
Tarsus Pharmaceuticals (TARS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $118.70M | $115.32M | 2.93 % |
| Q2 | 2025-08-06 | $102.66M | $94.84M | 8.24 % |
| Q1 | 2025-05-01 | $78.33M | $71.62M | 9.38 % |
| Q4 | 2025-02-25 | $66.41M | $58.80M | 12.9 % |
FAQ
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals (TARS) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
What were the latest earnings per share (EPS) for Tarsus Pharmaceuticals (NASDAQ:TARS)?
The Actual EPS was $-0.30, which beat the estimate of $-0.34.
What were Tarsus Pharmaceuticals’s (NASDAQ:TARS) revenues?
The Actual Revenue was $118.7M, which beat the estimate of $115.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
